MindMaze Therapeutics Announces Results of Annual General Meeting

GENEVA, June 25, 2026 /PRNewswire/ -- MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced the results of its Annual General Meeting held earlier today. Shareholders approved all...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.